Mark Sawicki, Chief Commercial Officer, discusses Cryoport, the life sciences industry’s global provider of temperature-controlled logistics solutions for temperature-sensitive life sciences commodities.
Dr. Jeanette Hill, the founder of Spot on Sciences, discusses the company. They market the HemaSpot™ device for the collection of dried blood samples. She also discusses the development currently underway on devices for collection of additional biological fluids including urine, saliva and tissue.
Dr Joshua Hirsch from Massachusetts General Hospital and Liz Thompson, CEO of the National Osteoporosis Foundation, discuss back injuries resulting from a number of conditions such as osteoporosis and vertebral compression fractures (VCF) and the latest technology to provide the most up-to-date treatment.
Circadian Optics is the maker of bright light therapy lamps to mimic daylight. Here to discuss this product and how she quit a job to create a smaller, better-designed lamp than what had been available, is founder Amber Leong. Circadian Optics lamps are an easy and effective way of getting exposure to bright light indoors.
On World Heart Health Day 2019, integrative cardiologist, Dr. Jason Kaplan joins us to discuss cardiovascular health issues in Australia and around the world, and evidence-based therapies to support heart health such as Ubiquinol, the active form of the powerful antioxidant, Coenzyme Q10 (CoQ10).
There has been an incredible surge in methamphetamine overdose deaths and In Ohio the surge has been as much as 130%. Dr. James Sturmi, MD, American Board of Addiction Medicine Fellow and Ohio Medical Director for Pinnacle Treatment Centers, discusses this increase in deaths, what the surge in meth is related to, eliminating the stigma associated with Medication Assisted Treatment (MAT), the prevalence of the opioid epidemic and the larger picture of treating substance use disorder (SUD).
Mike Kijewski, CEO, discusses MedCrypt, the company he launched in 2016 after seeing a particular 2012 episode of Homeland, that provides proactive cybersecurity solutions to medical device vendors.
Dr. Alyssa Dweck discusses this condition that many women are uncomfortable talking to their healthcare providers about. Hypoactive sexual desire disorder or HSDD is biological and not a result of issues or unhappiness. It can be handled with proper care and treatment. Learn more at Vyleesi. PRODUCT IS ONLY APPROVED FOR USE IN THE U.S.
Mike Davis, Head of the U.S. Neurology Patient Value Unit at UCB, a global pharmaceutical company, discusses the collaboration with the University of Washington’s School of Pharmacy to improve access to care for people living with epilepsy. This interdisciplinary project will explore ways in which community pharmacists can better support people living with this neurological disorder.
Dr. Jonathan Steinfeld, global clinical lead for the GSK mepolizumab pediatric asthma indication discusses the recent FDA approval of GSK’s Nucala (mepolizumab) the only biologic for use in children as young as 6 years old that have severe eosinophilic asthma.